Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05376059 · ClinicalTrials.gov registry record · NA
How v. How and Why Nudges and Rewards
A NA study of Control Condition and How Incentive Receive, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 60,000
- Enrollment target
- 1
- Study location
NCT05376059: Completed NA study of Control Condition and How Incentive Receive, sponsored by University of Pennsylvania.
NCT05376059 is a NA study of Control Condition and How Incentive Receive that has completed, run by University of Pennsylvania. The registered enrollment target is 60,000 participants, above the 87-participant average among 5 other Control Condition trials with a reported enrollment target (68866% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05376059, a NA study of Control Condition and How Incentive Receive, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 60,000 participants
- Enrollment target
- 1
- Study location
Study Summary
Members of CVS/Aetna will receive a direct mailing or receive no outreach at all. Our design will be a 3-cell between-subjects design: 1. control: this will be a group who will not receive any outreach 2. how: this will be a group that will receive a mailer emphasizing only how to seek treatment for mental health issues 3. how and why: this will be a mailer emphasizing both how to get help and why they should get help for mental health issues (i.e., listing out how mental health treatment can improve their lives). Within the how and how and why conditions, participants will be further divided into two different groups: 1. incentive ineligible 2. incentive eligible The incentive ineligible will receive the how or how and why mailer, depending on their condition. For the incentive eligible, they will again further be divided into the following two groups: 1. incentive holdout 2. incentive receive Those randomized into the incentive holdout group will receive the how or how and why mailer, depending on their condition. Those randomized into the incentive receive group will receive one of those two mailers, but it will also include an incentive if they seek out mental health treatment (if they visit a therapist within 30 days, they will receive a gift card).
Primary Outcome
Number of participants who visit the website to find a mental health appointment.
Conditions Studied
Interventions
- BEHAVIORAL Incentive
- BEHAVIORAL How Nudge
- BEHAVIORAL How and Why Nudge
Study Locations (1)
Pennsylvania
- Wharton Marketing Department - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60,000 participants |
| Start Date | 2022-04-24 |
| Est. Completion | 2023-05-01 |
| Phase | NA |
What the finished NCT05376059 record still lists
NCT05376059 is an interventional study that assigns participants to a tested intervention. Its 60,000 participants enrollment target places it among the larger protocols in the corpus, above the 87-participant average among 5 other Control Condition trials with a reported enrollment target (68866% higher).
The record links to 7 conditions, with Control Condition appearing as the primary indexed condition, and to 3 interventions - of which Incentive is the first listed.
NCT05376059 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05376059 about?
NCT05376059 is a clinical study titled "How v. How and Why Nudges and Rewards". Members of CVS/Aetna will receive a direct mailing or receive no outreach at all. Our design will be a 3-cell between-subjects design: 1. control: this will be a group who will not receive any outreach 2. how: this will be a group that will receive a mailer emphasizing only how to seek treatment f...
What is the current status of trial NCT05376059?
This trial is currently completed. It is a NA study. The enrollment target is 60,000 participants. The study started on 2022-04-24. Estimated completion is 2023-05-01.
What conditions does trial NCT05376059 study?
This clinical trial studies the following conditions: Control Condition, How Incentive Receive, How Incentive Holdout, How Incentive Ineligible, How and Why Incentive Receive.
What interventions are being tested in trial NCT05376059?
The interventions under investigation include: Incentive (BEHAVIORAL), How Nudge (BEHAVIORAL), How and Why Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT05376059?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05376059 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Control Condition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise and Protein Efficiency in T2D
RECRUITING · NA
-
Effect of Exercise and Heat Stress on Acute Cardiometabolic Adaptations in Healthy Young Adults
RECRUITING · NA
-
Foot Strengthening to Improve Balance and Gait in Older Adults
RECRUITING · NA
-
Disrupted Connections: The Impact of Acute Stress on Memory Integration
ACTIVE NOT RECRUITING · NA
-
Physical Exercise to Reduce Anxiety in Underserved Children With ASD
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00785525 · 60,000 participants · Phase 3
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
- NCT01825499 · 60,000 participants
Vermont Oxford Network Very Low Birth Weight Database
- NCT02850588 · 60,000 participants
SVS VQI TransCarotid Revascularization Surveillance Project
- NCT03752840 · 60,200 participants · NA
Village-Integrated Eye Worker Trial II
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI